General Information of Drug (ID: DMAVFG9)

Drug Name
5-Fluoro-2-deoxycytidine Drug Info
Synonyms FdCyd; 5-Fluoro-2'-deoxycytidine
Cross-matching ID
PubChem CID
515328
ChEBI ID
CHEMBL1076257
CAS Number
CAS 10356-76-0
TTD Drug ID
D0D1LS

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
p53 signaling pathway 2.64 0.00e+0 63/73 (86.3%) CDKN1A;SFN;RRM2;...
DNA replication 2.32 0.00e+0 34/36 (94.44%) RFC2;LIG1;FEN1;...
Pertussis 2.32 0.00e+0 64/76 (84.21%) C1S;CASP3;CASP7;...
Graft-versus-host disease 2.29 0.00e+0 32/42 (76.19%) HLA-B;FAS;PRF1;...
Allograft rejection 2.20 0.00e+0 32/38 (84.21%) HLA-B;FAS;PRF1;...
Glutathione metabolism 2.08 2.05e-3 43/57 (75.44%) RRM2;GSTA4;CHAC1;...
Epstein-Barr virus infection 2.05 1.76e-3 189/202 (93.56%) CDKN1A;RELB;CCNE2;...
Viral myocarditis 2.05 1.54e-3 53/60 (88.33%) HLA-B;SGCB;PRF1;...
Malaria 2.03 1.37e-3 44/50 (88%) CXCL8;VCAM1;IL6;...
Influenza A 1.98 1.23e-3 156/172 (90.7%) MX1;TNFSF10;SLC25A4;...
Drug metabolism 1.91 3.36e-3 78/151 (51.66%) RRM2;GSTA4;NAT1;...
TNF signaling pathway 1.91 3.08e-3 103/112 (91.96%) FAS;CXCL10;LIF;...
Pyrimidine metabolism 1.88 4.74e-3 40/56 (71.43%) RRM2;TYMS;UPP1;...
Viral protein interaction with cytokine and cytokine re... 1.87 5.28e-3 84/100 (84%) CXCL13;TNFSF10;TNFRSF10B;...
Type I diabetes mellitus 1.86 5.75e-3 38/43 (88.37%) HLA-B;FAS;PRF1;...
IL-17 signaling pathway 1.86 5.39e-3 84/94 (89.36%) CXCL10;S100A7;MUC5B;...
Nucleotide excision repair 1.85 5.07e-3 40/47 (85.11%) RFC2;DDB2;LIG1;...
NF-kappa B signaling pathway 1.84 4.79e-3 90/104 (86.54%) RELB;GADD45A;PLAU;...
Mismatch repair 1.82 6.49e-3 22/23 (95.65%) RFC2;LIG1;RFC4;...
Staphylococcus aureus infection 1.80 8.01e-3 72/95 (75.79%) KRT16;KRT14;KRT17;...
Metabolism of xenobiotics by cytochrome P450 1.78 8.22e-3 49/77 (63.64%) GSTA4;AKR7A2;ALDH3A1;...
Arachidonic acid metabolism 1.78 7.84e-3 48/61 (78.69%) AKR1C3;GPX1;PTGDS;...
Herpes simplex virus 1 infection 1.78 7.50e-3 165/498 (33.13%) HLA-B;IRF9;FAS;...
C-type lectin receptor signaling pathway 1.78 7.19e-3 93/104 (89.42%) RELB;IRF9;AKT1;...
Autoimmune thyroid disease 1.76 8.38e-3 46/53 (86.79%) HLA-B;FAS;PRF1;...
Viral carcinogenesis 1.76 8.06e-3 149/203 (73.4%) CDKN1A;CCNE2;HLA-B;...
Apoptosis 1.74 1.00e-2 126/168 (75%) TNFSF10;TNFRSF10B;FAS;...
Rheumatoid arthritis 1.71 1.72e-2 78/93 (83.87%) ATP6V1D;CTSK;ATP6V0E2;...
Small cell lung cancer 1.71 1.78e-2 90/92 (97.83%) CDKN1A;CCNE2;DDB2;...
Hepatitis C 1.70 1.77e-2 139/157 (88.54%) CDKN1A;MX1;CDK2;...
Ribosome biogenesis in eukaryotes -1.67 4.51e-2 52/108 (48.15%) NXF3;NAT10;GNL3L;...
Protein export -1.71 3.43e-2 17/23 (73.91%) SRPRB;SEC61B;SEC11A;...
RNA degradation -1.72 3.98e-2 53/79 (67.09%) TOB1;EXOSC10;LSM6;...
Aminoacyl-tRNA biosynthesis -1.74 3.78e-2 15/66 (22.73%) GATC;GATB;LARS2;...
Mineral absorption -1.84 1.14e-2 48/60 (80%) ATP1A1;MT2A;STEAP1;...
RNA transport -2.08 0.00e+0 128/186 (68.82%) RAE1;NUP214;RPP40;...
Spliceosome -2.44 0.00e+0 101/150 (67.33%) LSM3;HSPA1L;RBM8A;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 10uM 24H
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 3H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 3.33uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H